Anti-cancer drug IL-2 may finally be approved.
Stone
R
R
D003131:Combined Modality Therapy; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology; D009369:Neoplasms / Q000188:drug therapy / Q000628:therapy*; D014481:United States; D014486:United States Food and Drug Administration
D007376:Interleukin-2